1. Home
  2. BIVI vs PLAG Comparison

BIVI vs PLAG Comparison

Compare BIVI & PLAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • PLAG
  • Stock Information
  • Founded
  • BIVI 2013
  • PLAG 1986
  • Country
  • BIVI United States
  • PLAG United States
  • Employees
  • BIVI N/A
  • PLAG N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • PLAG Packaged Foods
  • Sector
  • BIVI Health Care
  • PLAG Consumer Staples
  • Exchange
  • BIVI Nasdaq
  • PLAG Nasdaq
  • Market Cap
  • BIVI 11.9M
  • PLAG 12.8M
  • IPO Year
  • BIVI N/A
  • PLAG N/A
  • Fundamental
  • Price
  • BIVI $1.82
  • PLAG $1.80
  • Analyst Decision
  • BIVI
  • PLAG
  • Analyst Count
  • BIVI 0
  • PLAG 0
  • Target Price
  • BIVI N/A
  • PLAG N/A
  • AVG Volume (30 Days)
  • BIVI 323.5K
  • PLAG 74.5K
  • Earning Date
  • BIVI 11-12-2025
  • PLAG 11-14-2025
  • Dividend Yield
  • BIVI N/A
  • PLAG N/A
  • EPS Growth
  • BIVI N/A
  • PLAG N/A
  • EPS
  • BIVI N/A
  • PLAG N/A
  • Revenue
  • BIVI N/A
  • PLAG $6,069,007.00
  • Revenue This Year
  • BIVI N/A
  • PLAG N/A
  • Revenue Next Year
  • BIVI N/A
  • PLAG N/A
  • P/E Ratio
  • BIVI N/A
  • PLAG N/A
  • Revenue Growth
  • BIVI N/A
  • PLAG N/A
  • 52 Week Low
  • BIVI $1.42
  • PLAG $0.47
  • 52 Week High
  • BIVI $75.00
  • PLAG $5.52
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 33.82
  • PLAG 53.97
  • Support Level
  • BIVI $1.54
  • PLAG $1.61
  • Resistance Level
  • BIVI $2.03
  • PLAG $2.02
  • Average True Range (ATR)
  • BIVI 0.15
  • PLAG 0.15
  • MACD
  • BIVI 0.23
  • PLAG 0.00
  • Stochastic Oscillator
  • BIVI 65.57
  • PLAG 45.20

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

Share on Social Networks: